Adams B, Chan A, Callahan H, Siwak C, Tapp D, Ikeda-Douglas C, Atkinson P, Head E, Cotman CW, Milgram NW.
Use of a delayed non-matching to position task to model age-dependent cognitive decline in the dog.
Behav Brain Res. 2000 Feb;108(1):47-56.
Satou T, Cummings BJ, Head E, Nielson KA, Hahn FF, Milgram NW, Velazquez P, Cribbs DH, Tenner AJ, Cotman CW.
The progression of beta-amyloid deposition in the frontal cortex of the aged canine.
Brain Res. 1997 Nov 7;774(1-2):35-43.
Head E, Callahan H, Cummings BJ, Cotman CW, Ruehl WW, Muggenberg BA, Milgram NW.
Open field activity and human interaction as a function of age and breed in dogs.
Physiol Behav. 1997 Nov;62(5):963-71.
Cummings BJ, Satou T, Head E, Milgram NW, Cole GM, Savage MJ, Podlisny MB, Selkoe DJ, Siman R, Greenberg BD, Cotman CW.
Diffuse plaques contain C-terminal A beta 42 and not A beta 40: evidence from cats and dogs.
Neurobiol Aging. 1996 Jul-Aug;17(4):653-9.
Head E, Hartley J, Kameka AM, Mehta R, Ivy GO, Ruehl WW, Milgram NW.
The effects of L-deprenyl on spatial short term memory in young and aged dogs.
Prog Neuropsychopharmacol Biol Psychiatry. 1996 Apr;20(3):515-30.
Milgram NW, Ivy GO, Murphy MP, Head E, Wu PH, Ruehl WW, Yu PH, Durden DA, Davis BA, Boulton AA.
Effects of chronic oral administration of L-deprenyl in the dog.
Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):421-8.
Ruehl WW, Bruyette DS, DePaoli A, Cotman CW, Head E, Milgram NW, Cummings BJ.
Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia and Alzheimer's disease: clinical presentation, cognitive testing, pathology and response to 1-deprenyl therapy.
Prog Brain Res. 1995;106:217-25.